| Patent application number | Description | Published |
|---|
| 20110004204 | Surgical Instrument and Method for Use Thereof - A surgical instrument for treating a tissue includes a handpiece and a tissue engaging portion arranged to be received by the handpiece. The tissue engaging portion includes first and second opposed jaw members having an open position and a closed position for engaging the tissue therebetween, where the first and second jaw members are arranged to receive surgical energy from a surgical generator. The tissue engaging portion further includes at least one cooling member spaced from at least one of the first and second jaw members, where the cooling member has an open position and a closed position for engaging the tissue. Positioning the jaw members in their closed position and applying surgical energy to the tissue allows for treatment of the tissue, and positioning the cooling member in its closed position provides at least one of a pressure gradient or a thermal gradient between the jaw members and the cooling member. | 01-06-2011 |
| 20140039371 | ACTIVE EXOSKELETAL SPINAL ORTHOSIS AND METHOD OF ORTHOTIC TREATMENT - An active exoskeletal spinal orthosis that can reduce the spinal compression and muscle effort involved in resisting gravitational bending moments. The spinal orthosis includes upper and lower members that fit around the body in the area of the spine. Actuators extend between the upper and lower members. By applying a corrective moment, a distraction force, or both to a user via the actuators, the spinal orthosis allows for supported multi-planar maneuverability within a set range of motion. A controller activates the actuators based on sensor feedback that is indicative of pressure or some other sensed physical parameter related to the bending moment. | 02-06-2014 |
| 20140128678 | AMBIDEXTROUS ERGONOMIC FACE MASK - A face mask that may be used for bag-mask ventilation, during the induction of general anesthesia for example, and allows for two-handed or ambidextrous use. The face mask includes a dome connected to a deformable rim, which forms an enclosed air space when the rim is pressed against a patient's face. The dome has a connection port and a contoured outer surface adjacent the connection port. The contoured outer surface includes contour features such as a pair of crossed composite recesses which may each receive a different one of a user's thumbs. The connection port is aligned with the patient's mouth when the mask is in use and an adapter may be included that attaches to the connection port and provides a ventilation port as well as an intubation port that is aligned with the mouth. | 05-08-2014 |
| Patent application number | Description | Published |
|---|
| 20090143476 | Antimicrobial Nanoemulsion Compositions and Methods - The present invention relates to compositions and methods for decreasing the infectivity, morbidity, and rate of mortality associated with a variety of pathogenic organisms and viruses. The present invention also relates to methods and compositions for decontaminating areas colonized or otherwise infected by pathogenic organisms and viruses. Moreover, the present invention relates to methods and compositions for decreasing the infectivity of pathogenic organisms in foodstuffs. | 06-04-2009 |
| 20090143477 | Antimicrobial Nanoemulsion Compositions and Methods - The present invention relates to compositions and methods for decreasing the infectivity, morbidity, and rate of mortality associated with a variety of pathogenic organisms and viruses. The present invention also relates to methods and compositions for decontaminating areas colonized or otherwise infected by pathogenic organisms and viruses. Moreover, the present invention relates to methods and compositions for decreasing the infectivity of pathogenic organisms in foodstuffs. | 06-04-2009 |
| 20100003330 | ANTIMICROBIAL NANOEMULSION COMPOSITIONS AND METHODS - The present invention relates to compositions and methods for decreasing the infectivity, morbidity, and rate of mortality associated with a variety of pathogenic organisms and viruses. The present invention also relates to methods and compositions for decontaminating areas colonized or otherwise infected by pathogenic organisms and viruses. Moreover, the present invention relates to methods and compositions for decreasing the infectivity of pathogenic organisms in foodstuffs. | 01-07-2010 |
| 20110070306 | Antimicrobial nanoemulsion compositions and methods - The present invention relates to compositions and methods for decreasing the infectivity, morbidity, and rate of mortality associated with a variety of pathogenic organisms and viruses. The present invention also relates to methods and compositions for decontaminating areas colonized or otherwise infected by pathogenic organisms and viruses. Moreover, the present invention relates to methods and compositions for decreasing the infectivity of pathogenic organisms in foodstuffs. | 03-24-2011 |
| 20110091556 | Antimicrobial compositions and methods of use - The present invention relates to compositions and methods for decreasing the infectivity, morbidity, and rate of mortality associated with a variety of pathogenic organisms and viruses. The present invention also relates to methods and compositions for decontaminating areas colonized or otherwise infected by pathogenic organisms and viruses. Moreover, the present invention relates to methods and compositions for decreasing the infectivity of pathogenic organisms in foodstuffs. In particular, decreased pathogenic organism infectivity, morbidity, and mortality is accomplished by contacting the pathogenic organism with an oil-in-water nanoemulsion comprising an oil, an organic solvent, and a surfactant dispersed in an aqueous phase. | 04-21-2011 |
| Patent application number | Description | Published |
|---|
| 20130253968 | FACILITY CONTROL SYSTEM (FCS, C1) TO MANAGE ASSETS PLANNING, DESIGN, CONSTRUCTION, FABRICATION, OPERATING, MAINTENCE AND PRODUCTS - A facility control system includes lab, field and construction equipment with a wireless transceiver to transmit machine generated actual initial measurement (AIM) data including GPS information from a field activity to a wide area network; a mobile computer with a wireless transceiver to transmit human generated data from an office, a remote lab, or a field test or inspection to the network; and a server coupled to the network, the server including a database to receive machine and human generated AIM data, wherein the server applies statistics and engineering methods to predict specification compliance and performance, wherein the AIM data is used with pre-formatted engineered designed data sheets that reflect the exact location of the event and required standards including incorporating best construction practices for installation of one or more construction items and materials quality to promote standardization, uniformity that insures contract compliance and minimizes non-conforming items in real time. | 09-26-2013 |
| 20140058963 | FACILITY CONTROL SYSTEM (FCS-C2) (INTRODUCTION OF TRAVELER FORM) TO MANAGE ASSETS PLANNING, DESIGN, CONSTRUCTION, FABRICATION, OPERATING, MAINTENCE AND PRODUCTS FABRICATION - A facility control system includes lab, field and construction equipment with a wireless transceiver to transmit machine generated actual initial measurement (AIM) data including GPS information from a field activity to a wide area network; a mobile computer with a wireless transceiver to transmit human generated data from an office, a remote lab, or a field test to the network; and a server coupled to the network, the server including a database to receive machine and human generated AIM data, wherein the server applies statistics and engineering methods to predict specification compliance and performance, wherein the AIM data is used with pre-formatted engineered designed data sheets, including checklist/traveler form, that reflect the exact location of the event and required standards including incorporating best construction practices for installation of construction items and materials quality to promote standardization, uniformity that insures contract compliance and minimizes non-conforming items in real time. | 02-27-2014 |
| Patent application number | Description | Published |
|---|
| 20140009213 | BODY-GATE COUPLING TO REDUCE DISTORTION IN RADIO-FREQUENCY SWITCH - Radio-frequency (RF) switch circuits are disclosed having one or more transistors coupled to provide improved harmonic management. The RF switch circuits including at least one field-effect transistor (FET) disposed between first and second nodes, each of the at least one FET having a respective body and gate. A coupling circuit can be configured to couple the respective body and gate of each of the at least one FET. The coupling circuit can include a capacitor electrically parallel with a diode. | 01-09-2014 |
| 20140009214 | CIRCUITS, DEVICES, METHODS AND APPLICATIONS RELATED TO SILICON-ON-INSULATOR BASED RADIO-FREQUENCY SWITCHES - Radio-frequency (RF) switch circuits are disclosed providing improved switching performance. An RF switch system includes a plurality of field-effect transistors (FETs) connected in series between first and second nodes, each FET having a gate and a body. A compensation network including a gate-coupling circuit couples the gates of each pair of neighboring FETs. The compensation network may further including a body-coupling circuit that couples the bodies of each pair of neighboring FETs. | 01-09-2014 |
| 20140300525 | METHODS FOR ANTENNA SWITCH MODULES - Methods for antenna switch modules are disclosed. In certain implementations, a method of making an antenna switch module is provided. The method includes providing a package substrate implemented to receive one or more electrical components, attaching a silicon on insulator (SOI) die to the package substrate, and providing an integrated filter. The SOI die includes a capacitor and a switch coupled to a plurality of radio frequency (RF) signal paths. The integrated filter filters an RF signal received on a first RF signal path of the plurality of RF signal paths, and includes the capacitor of the SOI die and an inductor. | 10-09-2014 |
| Patent application number | Description | Published |
|---|
| 20090048346 | THERAPEUTIC FORMULATIONS - The present invention features pharmaceutical compositions that improve the bioavailability of hydrophobic pharmaceutical agents that induce apoptosis in mammalian cells. Also featured are injectable formulations for the parenteral delivery of such hydrophobic pharmaceutical agents into patients in need of such treatment, as well as methods of making and using both the compositions and formulations, including methods for the treatment of cell proliferation or hyperproliferative diseases and disorders. | 02-19-2009 |
| 20090069350 | PHARMACEUTICAL COMPOSITIONS AND USE THEREOF - The present invention relates to pharmaceutical compositions and dosage compositions of compounds, including injectable formulations for the parenteral delivery of such compounds into patients in need of such treatment. Also featured are methods of making and using the compositions, including methods for the treatment of neoplastic diseases. | 03-12-2009 |
| 20090075962 | GROWTH STIMULANT COMPOSITIONS - An improved weight and growth stimulant for domesticated animals such as cattle, pigs and sheep is comprised of an anabolic agent that is subcutaneously administered in the form of a dual release implant formulation. Increased gains are particularly improved when zeranol is administered in an immediate-release and controlled-release formulation which allows for a one-time dosage injection. | 03-19-2009 |
| 20090264537 | BIODEGRADABLE BLOCK COPOLYMERIC COMPOSITIONS FOR DRUG DELIVERY - An improved drug delivery composition and method of use is disclosed. The composition comprises one or more biodegradable block copolymer drug carriers; and a reconstitution enhancing and enabling agent comprising polyethylene glycol (PEG), a PEG derivative or a mixture of PEG and a PEG derivative. The composition can be administered as is or after being be dissolved or rapidly reconstituted in an aqueous vehicle to afford a homogeneous solution or uniform colloidal systems. | 10-22-2009 |
| 20100076067 | BIODEGRADABLE BLOCK COPOLYMERIC COMPOSITIONS FOR DRUG DELIVERY - An improved drug delivery composition and method of use is disclosed. The composition comprises one or more biodegradable block copolymer drug carriers; and a reconstitution enhancing and enabling agent comprising polyethylene glycol (PEG), a PEG derivative or a mixture of PEG and a PEG derivative. The composition can be administered as is or after being be dissolved or rapidly reconstituted in an aqueous vehicle to afford a homogeneous solution or uniform colloidal systems. | 03-25-2010 |
| 20140105857 | COMPOSITIONS AND METHODS FOR ENHANCING ACTIVE AGENT ABSORPTION - Compositions and methods for enhancing the absorption of active agents across the mucosa of animal subjects are provided. Methods of administration and appropriate dosage forms are also provided. | 04-17-2014 |
| 20140113975 | BIODEGRADABLE BLOCK COPOLYMERIC COMPOSITIONS FOR DRUG DELIVERY - An improved drug delivery composition and method of use is disclosed. The composition comprises one or more biodegradable block copolymer drug carriers; and a reconstitution enhancing and enabling agent comprising polyethylene glycol (PEG), a PEG derivative or a mixture of PEG and a PEG derivative. The composition can be administered as is or after being be dissolved or rapidly reconstituted in an aqueous vehicle to afford a homogeneous solution or uniform colloidal systems. | 04-24-2014 |
| Patent application number | Description | Published |
|---|
| 20110156256 | ELECTROMIGRATION-RESISTANT UNDER-BUMP METALLIZATION OF NICKEL-IRON ALLOYS FOR SN-RICH SOLDER BUMPS OF PB-FREE FLIP-CHIP APPLICATIONS - A process comprises manufacturing an electromigration-resistant under-bump metallization (UBM) flip chip structure comprising a Cu layer by applying to the Cu layer a metallic reaction barrier layer comprising NiFe. The solder employed in the flip chip structure comprise substantially lead-free tin. A structure comprises a product produced by this process. In another embodiment a process comprises manufacturing an electromigration-resistant UBM Sn-rich Pb-free solder bump flip chip structure wherein the electromigration-resistant UBM structure comprises a four-layer structure, or a three-layer structure, wherein the four layer structure is formed by providing 1) an adhesion layer, 2) a Cu seed layer for plating, 3) a reaction barrier layer, and 4) a wettable layer for joining to the solder, and the three-layer structure is formed by providing 1) an adhesion layer, 2) a reaction barrier layer, and 3) a wettable layer. In a further embodiment, the reaction barrier layer comprises metals selected from Ni, Fe, Pd, Pt, Co, Cu and their alloys, and combinations thereof. A structure comprises a product produced by the immediately foregoing process. | 06-30-2011 |
| 20120252168 | Copper Post Solder Bumps on Substrate - A method comprises forming semiconductor flip chip interconnects where the flip chip comprises a wafer and a substrate having electrical connecting pads and electrically conductive posts operatively associated with the pads and extending away from the pads to terminate in distal ends. Solder bumping the distal ends by injection molding solder onto the distal ends produces a solder bumped substrate. Another embodiment comprises providing the substrate having the posts on the pads with a mask having a plurality of through hole reservoirs and aligning the reservoirs in the mask to be substantially concentric with the distal ends. This is followed by injecting liquid solder into the reservoirs to provide a volume of liquid solder on the distal ends, cooling the liquid solder in the reservoirs to solidify the solder, removing the mask to expose the solidified solder after the cooling and thereby provide a solder bumped substrate. This is followed by positioning the solder bumped substrate on a wafer in a manner that leaves a gap between the wafer and the substrate. The wafer has electrically conductive sites on the surface for soldering to the posts. Abutting the sites and the solder bumped posts followed by heating the solder to its liquidus temperature joins the wafer and substrate, after which, the gap is optionally filled with a material comprising an underfill. | 10-04-2012 |
| 20130062757 | No Flow Underfill or Wafer Level Underfill and Solder Columns - A preassembly semiconductor device comprises substrate soldering structures extending toward chip soldering structures for forming solder connections with the chip soldering structures, i.e., the chip and the substrate are in preassembly positions relative to one another. The height of the substrate soldering structures is greater than the height of the chip soldering structures. A pre-applied underfill is contiguous with the substrate and is sufficiently thick so as to extend substantially no further than the full height of the substrate soldering structures. In another embodiment the height of the chip soldering structures is greater than the height of the substrate soldering structures and the pre-applied underfill is contiguous with the semiconductor chip and sufficiently thick so as to extend substantially no further than the full height of the chip soldering structures. A process comprises manufacturing semiconductor assemblies from these devices by soldering the semiconductor chip and the substrate to one another. | 03-14-2013 |
| 20140057392 | Copper Post Solder Bumps on Substrates - A method comprises forming semiconductor flip chip interconnects having electrical connecting pads and electrically conductive posts terminating in distal ends operatively associated with the pads. We solder bump the distal ends by injection molding, mask the posts on the pads with a mask having a plurality of through hole reservoirs and align the reservoirs in the mask to be substantially concentric with the distal ends. Injecting liquid solder into the reservoirs and allowing it to cool provides solidified solder on the distal ends, which after mask removal produces a solder bumped substrate which we position on a wafer to leave a gap between the wafer and the substrate. The wafer has electrically conductive sites on the surface for soldering to the posts. Abutting the sites and the solder bumped posts followed by heating joins the wafer and substrate. The gap is optionally filled with a material comprising an underfill. | 02-27-2014 |
| 20140170816 | Copper Post Solder Bumps on Substrates - A method comprises forming semiconductor flip chip interconnects having electrical connecting pads and electrically conductive posts terminating in distal ends operatively associated with the pads. We solder bump the distal ends by injection molding, mask the posts on the pads with a mask having a plurality of through hole reservoirs and align the reservoirs in the mask to be substantially concentric with the distal ends. Injecting liquid solder into the reservoirs and allowing it to cool provides solidified solder on the distal ends, which after mask removal produces a solder bumped substrate which we position on a wafer to leave a gap between the wafer and the substrate. The wafer has electrically conductive sites on the surface for soldering to the posts. Abutting the sites and the solder bumped posts followed by heating joins the wafer and substrate. The gap is optionally filled with a material comprising an underfill. | 06-19-2014 |
| 20140370662 | Copper Post Solder Bumps on Substrates - A method comprises forming semiconductor flip chip interconnects having electrical connecting pads and electrically conductive posts terminating in distal ends operatively associated with the pads. We solder bump the distal ends by injection molding, mask the posts on the pads with a mask having a plurality of through hole reservoirs and align the reservoirs in the mask to be substantially concentric with the distal ends. Injecting liquid solder into the reservoirs and allowing it to cool provides solidified solder on the distal ends, which after mask removal produces a solder bumped substrate which we position on a wafer to leave a gap between the wafer and the substrate. The wafer has electrically conductive sites on the surface for soldering to the posts. Abutting the sites and the solder bumped posts followed by heating joins the wafer and substrate. The gap is optionally filled with a material comprising an underfill. | 12-18-2014 |
| 20150031173 | COPPER POST SOLDER BUMPS ON SUBSTRATES - A method comprises forming semiconductor flip chip interconnects having electrical connecting pads and electrically conductive posts terminating in distal ends operatively associated with the pads. We solder bump the distal ends by injection molding, mask the posts on the pads with a mask having a plurality of through hole reservoirs and align the reservoirs in the mask to be substantially concentric with the distal ends. Injecting liquid solder into the reservoirs and allowing it to cool provides solidified solder on the distal ends, which after mask removal produces a solder bumped substrate which we position on a wafer to leave a gap between the wafer and the substrate. The wafer has electrically conductive sites on the surface for soldering to the posts. Abutting the sites and the solder bumped posts followed by heating joins the wafer and substrate. The gap is optionally filled with a material comprising an underfill. | 01-29-2015 |
| Patent application number | Description | Published |
|---|
| 20100088121 | MEDICAL INFORMATION NOTIFICATION SYSTEM USING SECURE WIRELESS AND/OR WIRED COMMUNICATION - A system for reporting medical information to healthcare provider users may require users to acknowledge receipt of information. Information may be sent using a secure instant messaging (SIM) protocol, and users may acknowledge receipt, e.g., by sending a message, or clicking on a uniform resource locator (URL) or button included in the information. Unacknowledged information may be re-sent at designated time intervals, and may have different levels of urgency indicated in the message. Acknowledgement may be tracked by the system, e.g., by recording the user and timestamp of acknowledgement. Feeds or syndications (e.g., RSS, RDF, Atom, etc.) may be used to provide medical information, allowing users to subscribe to feeds for one or more patients. Feeds may be continuously aggregated and updated with the most recent information for each of the patients. Users can easily distinguish new information from information already accessed, thereby allowing the healthcare provider to efficiently sort through the medical data. | 04-08-2010 |
| 20120106817 | SYSTEM AND METHOD FOR RADIATION DOSE REPORTING - Systems and method can be employed to automatically extract radiation dose information from medical images, particularly a plurality of heterogeneous CT images including those from legacy CT scanners. A report including the extracted radiation dose information can be generated, and alerts can be sent to reduce the possibility of overexposures. | 05-03-2012 |
| Patent application number | Description | Published |
|---|
| 20100158924 | Expression of the cysteine protease legumain in vascular and inflammatory diseases - The present invention provides isolated and purified polynucleotides, polypeptides, and antibodies related to mammalian (e.g., mouse and human) legumain and the novel legumain splice variant, ZB-1. The invention further relates to the use of these isolated and purified polynucleotides, polypeptides, and antibodies, as well as other legumain and ZB-1 agonists and antagonists, in modulating legumain and/or ZB-1 activity, expression, and/or secretion in a cell or cell population, e.g., monocytes, macrophages, foam cells, vascular endothelial cells, kidney proximal tubule cells, arterial endothelial cells, sites of inflammatory cell invasion into a vessel intima, and neointimal lesional areas of an artery. The invention also provides legumain and ZB-1 antagonists, e.g., antagonistic small molecules, antibodies and antibody fragments to legumain and ZB-1, legumain and ZB-1 inhibitory polypeptides, and legumain and ZB-1 inhibitory polynucleotides. The present invention is also directed to novel methods for diagnosing, prognosing, monitoring, treating, ameliorating and/or preventing vascular disorders/diseases and inflammatory disorders/diseases. | 06-24-2010 |
| Patent application number | Description | Published |
|---|
| 20110286994 | METHODS AND COMPOSITIONS FOR IMPROVING GROWTH OF MEAT-TYPE POULTRY - The present invention provides methods of improving growth performance, improving the efficiency of feed utilization, increasing feed digestibility, and decreasing mortality of immature and developing animals receiving animal feed. Methods of producing a crude keratinase enzyme extract and animal feed supplements for achieving the same are also provided. | 11-24-2011 |
| 20140044700 | METHODS AND COMPOSITIONS FOR IMPROVING GROWTH OF MEAT-TYPE POULTRY - The present invention provides methods of improving growth performance, improving the efficiency of feed utilization, increasing feed digestibility, and decreasing mortality of immature and developing animals receiving animal feed. Methods of producing a crude keratinise enzyme extract and animal feed supplements for achieving the same are also provided. | 02-13-2014 |
| 20150037458 | METHODS AND COMPOSITIONS FOR IMPROVING GROWTH OF MEAT-TYPE POULTRY - The present invention provides methods of improving growth performance, improving the efficiency of feed utilization, increasing feed digestibility, and decreasing mortality of immature and developing animals receiving animal feed. Methods of producing a crude keratinise enzyme extract and animal feed supplements for achieving the same are also provided. | 02-05-2015 |
| Patent application number | Description | Published |
|---|
| 20080280377 | HUMAN B-TYPE NATRIURETIC PEPTIDE ASSAY HAVING REDUCED CROSS-REACTIVITY WITH OTHER PEPTIDE FORMS - The present disclosure provides among other things assays, methods and kits for assessing the presence or amount of human B-type natriuretic peptide in a test sample wherein the assay exhibits reduced cross-reactivity with other forms of the peptide. | 11-13-2008 |
| 20080286818 | BLOOD SAMPLE HANDLING METHODS FOR IMPROVED ASSAYS FOR MYELOPEROXIDASE - The invention provides a method for determining concentration of myeloperoxidase (MPO) in a human blood sample comprising: (a) providing a human peripheral blood sample stored under MPO preservation conditions; and (b) determining concentration of MPO in a plasma sample derived from the human peripheral blood sample. In a preferred embodiment, the MPO preservation conditions used in the invention comprise storage of the human peripheral blood sample in a plasma collection tube containing a leukocyte MPO secretion inhibitor. In this embodiment, the leukocyte MPO secretion inhibitor is preferably ethylene diamine tetraacetic acid (EDTA). The assays used in the inventive methods can comprise any clinically useful assay for determining MPO plasma concentration, including sandwich and competitive immunoassays, clinical chemistry assays and enzymatic assays. | 11-20-2008 |
| 20090123473 | HUMAN BNP IMMUNOSPECIFIC ANTIBODIES - The present invention relates to antibodies that immunospecifically bind to human brain natriuretic peptide or a human brain natriuretic peptide fragment with a high binding affinity, methods for producing and selecting said antibodies, immunoassays for human brain natriuretic peptide or a human brain natriuretic peptide fragment that employ said antibodies and therapeutic compositions containing said antibodies. | 05-14-2009 |
| 20090148866 | Antibodies and Improved Test Sample Handling Methods for Use in Assays for Myeloperoxidase - The present disclosure relates to isolated antibodies that can be used in an assay to determine the concentration levels of myeloperoxidase (MPO) in a test sample. Additionally, the present disclosure also relates to the use of improved test sample handling methods in assays in order to preserve the original MPO levels in the test sample. | 06-11-2009 |
| 20110053179 | Biomarkers For Prediction Of Major Adverse Cardiac Events And Uses Thereof - The present invention relates to combinations of biomarkers and levels thereof that may be used, for example, in the determination of risk associated with the occurrence of a major adverse cardiac event (MACE) in a patient. | 03-03-2011 |
| 20110201130 | HUMAN B-TYPE NATRIURETIC PEPTIDE ASSAY HAVING REDUCED CROSS-REACTIVITY WITH OTHER PEPTIDE FORMS - The present disclosure provides among other things assays, methods and kits for assessing the presence or amount of human B-type natriuretic peptide in a test sample wherein the assay exhibits reduced cross-reactivity with other forms of the peptide. | 08-18-2011 |
| 20130288269 | Biomarkers For Prediction Of Major Adverse Cardiac Events And Uses Thereof - The present invention relates to combinations of biomarkers and levels thereof that may be used, for example, in the determination of risk associated with the occurrence of a major adverse cardiac event (MACE) in a patient. | 10-31-2013 |
| Patent application number | Description | Published |
|---|
| 20080227107 | COMPOSITIONS AND METHODS FOR LABELING OF NUCLEIC ACID MOLECULES - The present invention is generally related to compositions, kits and methods for labeling nucleic acid molecules using reverse transcriptases, preferably multi-subunit reverse transcriptases such as ASLV reverse transcriptases. Specifically, the invention relates to methods, kits and compositions for fluorescently labeling nucleic acid molecules during nucleic acid synthesis. The labeled nucleic acid molecules produced in accordance with the invention are particularly suited as labeled probes for nucleic acid detection and diagnostics. | 09-18-2008 |
| 20090176242 | COMPOSITIONS AND METHODS FOR LABELING OF NUCLEIC ACID MOLECULES - The present invention is generally related to compositions, kits and methods for labeling nucleic acid molecules using reverse transcriptases, preferably multi-subunit reverse transcriptases such as ASLV reverse transcriptases. Specifically, the invention relates to methods, kits and compositions for fluorescently labeling nucleic acid molecules during nucleic acid synthesis. The labeled nucleic acid molecules produced in accordance with the invention are particularly suited as labeled probes for nucleic acid detection and diagnostics. | 07-09-2009 |
| 20100168408 | COMPOSITIONS AND METHODS FOR LABELING OF NUCLEIC ACID MOLECULES - The present invention is generally related to compositions, kits and methods for labeling nucleic acid molecules using reverse transcriptases, preferably multi-subunit reverse transcriptases such as ASLV reverse transcriptases. Specifically, the invention relates to methods, kits and compositions for to fluorescently labeling nucleic acid molecules during nucleic acid synthesis. The labeled nucleic acid molecules produced in accordance with the invention are particularly suited as labeled probes for nucleic acid detection and diagnostics. | 07-01-2010 |
| Patent application number | Description | Published |
|---|
| 20110159176 | METHOD OF MAKING FUSER MEMBER - A method of making a fuser member having an annealed outer surface comprising: providing an outer layer comprising compatible first and second fluorothermoplastics over an outer substrate surface, wherein the first fluorothermoplastic is a crosslinkable polymer and the second fluorothermoplastic is a linear polymer; curing the outer layer to crosslink the first fluorothermoplastic whereby the resulting crosslinked first fluorothermoplastic and the linear polymer second fluorothermoplastic form a semi-interpenetrating polymer network (SIPN); and annealing an outer surface of the outer layer by contacting the fuser member with applied pressure against a heated surface, without first sintering the second fluorothermoplastic linear polymer through application of heat alone. | 06-30-2011 |
| 20110159276 | FUSER MEMBER WITH FLUOROPOLYMER OUTER LAYER - A fuser member comprising: a substrate comprising an outer substrate surface; and an outer layer comprising compatible first and second fluorothermoplastics disposed over the outer substrate surface, wherein the first fluorothermoplastic is a crosslinked polymer and the second fluorothermoplastic is a linear polymer and wherein the compatible first and second fluorothermoplastics form a semi-interpenetrating polymer network (SIPN). The SIPN provides a relatively compliant layer in comparison to use of the crosslinked polymer alone, and avoids the need for sintering of a layer formed from the linear polymer alone. The SIPN may be formed from an aqueous coated composition of polyperfluoroalkoxy-tetrafluoroethylene (PFA) and THV Fluoroplastics (FLC) polymers along with a soluble organic primary amine for crosslinking the THV Fluoroplastics (FLC). | 06-30-2011 |
| 20120077000 | PROCESS FOR PRODUCING AN IMAGE FROM POROUS MARKING PARTICLES - A process of producing an image including transferring porous polymeric marking particles to a receiver, and fixing the marking particles to the receiver by applying heat and pressure by contacting the marking particles with a heated fuser member including a topcoat layer having a storage modulus of at least 10 MPa at 175° C. In particular embodiments, the invention is specifically directed towards fusing porous toner materials, and enables reducing the image relief, toner spread, and differential gloss of resulting fused toner images. Higher gloss and reduced differential gloss is obtained at similar or reduced toner spread, measured by toner particle area gain, allowing the use of reduced fusing conditions compared to solid toners. | 03-29-2012 |
| Patent application number | Description | Published |
|---|
| 20130041175 | PROCESS FOR OXIDIZING ALKYL AROMATIC COMPOUNDS - A process for oxidizing an alkyl-aromatic compound is described. The process includes contacting the alkyl-aromatic compound, a solvent comprising an ionic liquid, a bromine source, a catalyst, and an oxidizing agent in a first reaction zone to produce a first product comprising a first mother liquor and at least one of an aromatic alcohol, an aromatic aldehyde, an aromatic ketone, and an aromatic carboxylic acid. | 02-14-2013 |
| 20140100403 | LOW PRESSURE TRANSALKYLATION PROCESS - A process for transalkylation is described. The process operates at a lower pressure than a typical transalkylation processes, and provides higher benzene purity with comparable or lower ring loss compared to the typical transalkylation process. The xylene selectivity is comparable to or higher than the standard process, and the ethyl benzene selectivity is comparable to or lower than the standard process. | 04-10-2014 |
| 20140171679 | OXIDATION AND CRYSTALLIZATION PROCESS FOR AROMATIC CARBOXYLIC ACID PRODUCTION - A process for oxidizing and crystallizing alkyl aromatics is described. The solvent and operating conditions are controlled to maintain the aromatic carboxylic acid in solution in the reaction zone, and the aromatic carboxylic acid is crystallized in a downstream crystallizer, resulting in reduced impurity levels in the product. | 06-19-2014 |
| Patent application number | Description | Published |
|---|
| 20100155300 | Process for producing gasoline of increased octane and hydrogen-containing co-produced stream - The present invention is directed to a process for producing an increased yield of gasoline of increased octane rating by the integration of a membrane separation processing step into the gasoline production process. The integrated process also increases hydrogen production from the reformer. | 06-24-2010 |
| 20100155332 | Process for improving the cetane rating of distillate and diesel boiling range fractions - The present invention is directed to a process for producing a diesel fuel of enhanced cetane value from low cetane distillate and diesel boiling range fractions from poor crudes such as naphthenic crudes. | 06-24-2010 |
| 20110132803 | TWO STAGE HYDROPROCESSING WITH DIVIDED WALL COLUMN FRACTIONATOR - A divided wall column allows for fractionation of multiple streams while maintaining separate product qualities. Effluents from multiple stages of a reaction system can be processed in a single divided wall column. The divided wall column can produce multiple cuts from each separated area, as well as at least one output from a common area. | 06-09-2011 |
| 20110240521 | HYDROPROCESSING OF GAS OIL BOILING RANGE FEEDS - A system and method for producing fuels and lubricant basestocks from gas oil boiling range feeds is provided. Desulfurization and conversion stages are used to form fuel and lubricant products. The product from a desulfurization stage can be fractionated, and a portion of the fractionated bottoms can be used as an input feed for a conversion or hydrocracking stage. The configuration can advantageously allow for reduced amounts of catalyst in the conversion stage. | 10-06-2011 |
| 20110282118 | METHOD FOR MAKING DIESEL WITH LOW POLYAROMATIC CONTENT - Distillate feeds are hydroprocessed to produce a product having a low content of polyaromatic hydrocarbons (PAHs). The hydroprocessing includes dewaxing and aromatic saturation of the feed. The temperature of the aromatic saturation process can be controlled to make a distillate product having a desired aromatic content, such as less the 0.02 wt % of polyaromatic hydrocarbons having three or more aromatic rings. | 11-17-2011 |
| 20120000817 | Production of Low Color Middle Distillate Fuels - In a process for producing a low color diesel and/or kerosene fuel, a middle distillate feed can be supplied to a reactor having at least one first catalyst bed containing a first desulfurization and/or isomerization catalyst and at least one second catalyst bed containing a decolorization catalyst downstream from the first catalyst bed(s). The feed can be reacted with the hydrogen in the presence of the first catalyst at a temperature from about 290° C. to about 430° C. to produce a first liquid effluent, which can be cooled by about 10° C. to about 40° C. with a quench medium and cascaded to the at least one second catalyst bed. The cooled first liquid effluent can then be reacted with hydrogen in the presence of the decolorization catalyst at a temperature from about 280° C. to about 415° C. to produce a second effluent having an ASTM color less than 2.5. | 01-05-2012 |
| 20120080357 | HYDROCRACKING PROCESS SELECTIVE FOR IMPROVED DISTILLATE AND IMPROVED LUBE YIELD AND PROPERTIES - This invention relates to a process involving hydrocracking of a feedstream in which a converted fraction can exhibit relatively high distillate product yields and maintained or improved distillate fuel properties, while an unconverted fraction can exhibit improved properties particularly useful in the lubricant area. | 04-05-2012 |
| 20120152803 | INCREASING FUEL SMOKE POINT - The present invention relates to processes for increasing smoke point of a fuel. The process can be carried out using an upgrading catalyst that contains at least one noble metal supported on an inorganic, porous crystalline phase material. The catalyst is particularly effective in increasing smoke point, while minimizing reduction in total aromatics content, particularly naphthalene content. | 06-21-2012 |
| 20120248008 | FUELS HYDROCRACKING WITH DEWAXING OF FUEL PRODUCTS - This invention relates to a process involving hydrocracking and dewaxing of a feedstream in which a converted fraction can correspond to a majority of the product from the reaction system, while an unconverted fraction can exhibit improved properties. In this hydrocracking process, it can be advantageous for the yield of unconverted fraction for gasoline fuel application to be controlled to maintain desirable cold flow properties for the unconverted fraction. Catalysts and conditions can be chosen to assist in attaining, or to optimize, desirable product yields and/or properties. | 10-04-2012 |
| 20130112594 | PRODUCTION OF LOW CLOUD POINT DISTILLATES - Systems and methods are provided for producing at least one low sulfur distillate fuel product with improved low temperature properties. A potential distillate fuel feed is initially hydrotreated to reduce sulfur and nitrogen levels in the feed to desired amounts. The hydrotreated effluent is then fractionated to form several fractions, including a light diesel/distillate fraction and a heavy diesel fraction. The heavy diesel fraction is then dewaxed to improve the cold flow properties of the heavy diesel fraction. The dewaxed heavy diesel fraction can be combined with the light diesel fraction, or the dewaxed heavy diesel fraction can be fractionated as well. Optionally, the heavy diesel fraction is dewaxed under conditions effective for producing a dewaxed fraction with a cloud point that is less than or equal to the cloud point of the light diesel/distillate fraction. | 05-09-2013 |
| 20130341243 | HYDROCRACKING PROCESS SELECTIVE FOR IMPROVED DISTILLATE AND IMPROVED LUBE YIELD AND PROPERTIES - This invention relates to a process involving hydrocracking of a feedstream in which a converted fraction can exhibit relatively high distillate product yields and maintained or improved distillate fuel properties, while an unconverted fraction can exhibit improved properties particularly useful in the lubricant area. In this hydrocracking process, it can be advantageous for the yield of converted/unconverted product for gasoline fuel application to be reduced or minimized, relative to converted distillate fuel and unconverted lubricant. Catalysts and conditions can be chosen to assist in attaining, or to optimize, desirable product yields and/or properties. | 12-26-2013 |
| Patent application number | Description | Published |
|---|
| 20110081510 | MELT STRENGTH ENHANCED COPOLYESTER WITH IMPROVED STABILITY AND PROFILE IN BLOWN FILM - The invention relates to blown films and methods of making blown films using a melt-strength enhanced polyester composition. The composition has a zero-shear viscosity and a degree of shear thinning that are comparable to PVC's melt rheology. The polyester composition has a branching agent and/or a fluoropolymer processing additive and an inherent viscosity of at least 0.60 dl/g. The diacid component of the polyester composition comprises 97 to 100 mole percent of residues of terephthalic acid, naphthalenedicarboxylic acid, isophthalic acid or mixtures thereof. The glycol component of the polyester composition comprises 97 to 100 mole percent of residues of ethylene glycol, 1,4-cyclohexanedimethanol, diethylene glycol, neopentyl glycol or mixtures thereof. | 04-07-2011 |
| 20110091705 | RADIO-FREQUENCY SEALABLE POLYMER AND ARTICLES THEREOF - The present invention relates to a reactor-grade copolyester composition having radio-frequency sealing capability. The present invention further relates to films and thermoformable packaging prepared from the reactor-grade copolyester composition. | 04-21-2011 |
| 20140162042 | COPOLYESTERS PLASTICIZED WITH POLYMERIC PLASTICIZER FOR SHRINK FILM APPLICATIONS - Disclosed is a shrink film containing a copolyester having a minimum crystallization half-time of at least 8.6 minutes and a polyester plasticizer having a weight-average molecular weight of 900 to 12,000 g/mol. The polyester plasticizer includes (i) a polyol component comprising residues of a polyol having 2 to 8 carbon atoms, and (ii) a diacid component comprising residues of a dicarboxylic acid having 4 to 12 carbon atoms. | 06-12-2014 |
| 20140238585 | RADIO-FREQUENCY SEALABLE POLYMER AND ARTICLES THEREOF - The present invention relates to a reactor-grade copolyester composition having radio-frequency sealing capability. The present invention further relates to films and thermoformable packaging prepared from the reactor-grade copolyester composition and the methods for making such films and articles therefrom. | 08-28-2014 |
| Patent application number | Description | Published |
|---|
| 20100216978 | WIREFRAME NANOSTRUCTURES - The present invention generally relates to nanotechnology and, in particular, to wireframe nanostructures which may be formed from nucleic acids. In various aspects, the invention relates to molecular structures having a plurality of vertices and pathways connecting the vertices, which may be formed from nucleic acids, including bundles or tubes of nucleic acids. Such molecular structures may form shapes such as icosahedrons, octahedrons, tetrahedrons, or other polyhedra, which may define an interior space. The interior space may be used, for example, to contain a molecule for further study, or to contain a molecule for drug delivery purposes. In some cases, the molecular structure may be stabilized using relatively short nucleic acid strands that interact with two or more nucleic acid portions within the structure, thereby substantially immobilizing the portions relative to each other. Other aspects of the invention relate to techniques for forming such molecular structures, techniques for using such molecular structures, techniques of promoting such molecular structures, kits involving such molecular structures, and the like. | 08-26-2010 |
| Patent application number | Description | Published |
|---|
| 20110089944 | NUCLEIC ACID NANOTUBE LIQUID CRYSTALS AND USE FOR NMR STRUCTURE DETERMINATION OF MEMBRANE PROTEINS - Compositions and methods for preparing nucleic acid nanotubes using DNA origami techniques are described, which provide for nanotubes of predictable and uniform length. The nucleic acid nanotubes thus formed are suitable as liquid crystal preparations enabling liquid-crystal NMR spectroscopy of proteins solubilized in detergent. | 04-21-2011 |
| 20110260105 | NUCLEIC ACID NANOTUBE LIQUID CRYSTALS AND USE FOR NMR STRUCTURE DETERMINATION OF MEMBRANE PROTEINS - Compositions and methods for preparing nucleic acid nanotubes using DNA origami techniques are described, which provide for nanotubes of predictable and uniform length. The nucleic acid nanotubes thus formed are suitable as liquid crystal preparations enabling liquid-crystal NMR spectroscopy of proteins solubilized in detergent. | 10-27-2011 |
| 20130261019 | NUCLEIC ACID NANOSTRUCTURE BARCODE PROBES - Provided herein are, inter alia, barcode probes comprised of transiently or stably fhiorescently labeled nucleic acid nanostructures that are fully addressable and able to be read using standard fluorescent microscope and methods of use thereof including methods of use as detectable labels for probes. | 10-03-2013 |
| 20150024972 | SELECTIVE NUCLEIC ACID AMPLIFICATION FROM NUCLEIC ACID POOLS - Provided herein are nucleic acids and methods for selectively amplifying in parallel tens of thousands of high quality oligonucleotides without common sequences. The resultant oligonucleotides can be used for a variety of purposes and applications including but not limited to DNA nano structure synthesis. | 01-22-2015 |
| 20150064233 | LIPID-COATED NUCLEIC ACID NANOSTRUCTURES OF DEFINED SHAPE - The invention provides nanoparticles containing a nucleic acid nanostructure, of defined shape and size, linked to a hydrophobic moiety and coated by lipids, compositions comprising the nanoparticles, and methods of producing and methods of using the nanoparticles. | 03-05-2015 |
